pancreatic cancer cases
cancer women
PancREatic Cancer Early DEtection
aiding diagnosis of pancreatic cancer
Ovarian Cancer Screening
algorithm
devastating disease
marker CA19
screening healthy high risk individuals
individualâ€™s healthy baseline of CA19
longitudinal pre-diagnosis levels of CA19
healthy controls
clinical trial
clinical validation
personalised screening diagnostic
population
specificity
commercialisation
year survival
years
Abcodia
high number of false positives
symptomatic individuals
UK Collaborative Trial
test increases sensitivity
spotting inflection points
standard diagnostic practice
approved biomarker
robust business plan
natural variation
regular testing
project
symptoms
examples
values
Europe
flat profiles
therapy
performance
time patients
recent EU study
phase
effective way
personalisation
incidence
mortality
figure